Mostrar el registro sencillo del ítem

dc.contributor.authorFernández de la Pradilla Ibáñez, Adrián
dc.contributor.authorRoyo, Santiago
dc.contributor.authorSchirmeister, Tanja
dc.contributor.authorBarthels, Fabian
dc.contributor.authorŚwiderek, Katarzyna
dc.contributor.authorGonzález, Florenci
dc.contributor.authorMoliner, Vicent
dc.date.accessioned2023-12-22T07:58:34Z
dc.date.available2023-12-22T07:58:34Z
dc.date.issued2023-10-03
dc.identifier.citationFernández-de-la-Pradilla, A.; Royo, S.; Schirmeister, T.; Barthels, F.; Świderek, K.; González, F. V.; Moliner, V. Impact of the Warhead of Dipeptidyl Keto Michael Acceptors on the Inhibition Mechanism of Cysteine Protease Cathepsin L. ACS Catal. 2023, 13 (20), 13354-13368, DOI: 10.1021/acscatal.3c02748ca_CA
dc.identifier.issn2155-5435
dc.identifier.urihttp://hdl.handle.net/10234/205266
dc.description.abstractCathepsin L (CatL) is a lysosomal cysteine protease whose activity has been related to several human pathologies. However, although preclinical trials using CatL inhibitors were promising, clinical trials have been unsuccessful up to now. We are presenting a study of two designed dipeptidyl keto Michael acceptor potential inhibitors of CatL with either a keto vinyl ester or a keto vinyl sulfone (KVS) warhead. The compounds were synthesized and experimentally assayed in vitro, and their inhibition molecular mechanism was explored based on molecular dynamics simulations at the density functional theory/molecular mechanics level. The results confirm that both compounds inhibit CatL in the nanomolar range and show a time-dependent inhibition. Interestingly, despite both presenting almost equivalent equilibrium constants for the reversible formation of the noncovalent enzyme/inhibitor complex, differences are observed in the chemical step corresponding to the enzyme–inhibitor covalent bond formation, results that are mirrored by the computer simulations. Theoretically determined kinetic and thermodynamic results, which are in very good agreement with the experiments, afford a detailed explanation of the relevance of the different structural features of both compounds having a significant impact on enzyme inhibition. The unprecedented binding interactions of both inhibitors in the P1′ site of CatL represent valuable information for the design of inhibitors. In particular, the peptidyl KVS can be used as a starting lead compound in the development of drugs with medical applications for the treatment of cancerous pathologies since sulfone warheads have previously shown promising cell stability compared to other functions such as carboxylic esters. Future improvements can be guided by the atomistic description of the enzyme–inhibitor interactions established along the inhibition reaction derived from computer simulations.ca_CA
dc.description.sponsorShipFunding for open access charge: CRUE-Universitat Jaume I
dc.format.extent15 p.ca_CA
dc.format.mimetypeapplication/pdfca_CA
dc.language.isoengca_CA
dc.publisherAmerican Chemical Societyca_CA
dc.relationEstudios computacionales del mecanismo y la inhibición de la proteólisis enzimática como enfoque complementario del mundo del descubrimiento moderno de fármacosca_CA
dc.relation.isPartOfACS catalysis, 2023, vol. 13, no 20ca_CA
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/ca_CA
dc.subjectcathepsin Lca_CA
dc.subjectinhibitorca_CA
dc.subjectQM/MMca_CA
dc.subjectMDca_CA
dc.subjectMichael acceptorca_CA
dc.titleImpact of the Warhead of Dipeptidyl Keto Michael Acceptors on the Inhibition Mechanism of Cysteine Protease Cathepsin Lca_CA
dc.typeinfo:eu-repo/semantics/articleca_CA
dc.identifier.doihttps://doi.org/10.1021/acscatal.3c02748
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessca_CA
dc.relation.publisherVersionhttps://pubs.acs.org/doi/full/10.1021/acscatal.3c02748ca_CA
dc.description.sponsorshipThis work was supported by the Spanish Ministerio de Ciencia, Innovación y Universidades (grant PGC2021-23332OB-C21 and PID2019-107098RJ-I00), the Generalitat Valenciana (PROMETEO, with ref CIPROM/2021/079), and Universitat Jaume I (UJI-B2020-03 and UJI-2021-71). A.F.P thanks MINECO for the doctoral FPU grant (FPU AP-2020-03516). K.Ś. thanks the Ministerio de Ciencia e Innovación and Fondo Social Europeo for a Ramon y Cajal contract (ref. RYC2020-030596-I) and a European Cooperation in Science & Technology COST Action (ref CA21101). The authors thankfully acknowledge the computational resources funded by the Spanish Ministry of Science─European Regional Development Fund (REF: EQC2019-006018-P) installed at Universitat Jaume I, the Servei d’Informàtica and Serveis Centrals d’Instrumentació Científica of Universitat Jaume I.
dc.type.versioninfo:eu-repo/semantics/publishedVersionca_CA
project.funder.identifierhttp://dx.doi.org/10.13039/501100011033ca_CA
project.funder.nameMinisterio de Ciencia e Innovaciónca_CA
project.funder.nameMinisterio de Ciencia, Innovación y Universidadesca_CA
project.funder.nameGeneralitat Valencianaca_CA
project.funder.nameUniversitat Jaume Ica_CA
project.funder.nameEuropean Cooperation in Science and Technology (COST)ca_CA
oaire.awardNumberMCIN/PEICTI2021-2023/PGC2021-23332OB-C21ca_CA
oaire.awardNumberMICIU/ICTI2017-2020/PID2019-107098RJ-I00ca_CA
oaire.awardNumberCIPROM/2021/079ca_CA
oaire.awardNumberUJI-B2020-03ca_CA
oaire.awardNumberUJI-2021-71ca_CA
oaire.awardNumberFPU AP-2020-03516ca_CA
oaire.awardNumberRYC2020-030596-Ica_CA
oaire.awardNumberCA21101ca_CA
oaire.awardNumberEQC2019-006018-Pca_CA
dc.subject.ods3. Salud y bienestarca_CA


Ficheros en el ítem

Thumbnail
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

http://creativecommons.org/licenses/by/4.0/
Excepto si se señala otra cosa, la licencia del ítem se describe como: http://creativecommons.org/licenses/by/4.0/